Evidence map›Paper›PMID 33098017›Full record

ArticlePharmaceutical research2020

Formation of an Unprecedented Impurity during CE-SDS Analysis of a Recombinant Protein.

Bin-Bin Shen, Zhongwei Zhang, Jun-Jie Yuan, Aiping Zheng, Su Zeng, Jian-Qing Gao, Wenhan Bao, James Barnard, Haibin Wang, Wei-Jie Fang

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 10 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Bin-Bin ShenInstitute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Zhongwei ZhangInstitute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Jun-Jie YuanZhejiang Hisun Bioray Biopharmaceutical Co., Ltd, Taizhou, Zhejiang, 318000, China.
Aiping ZhengInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, 100850, China.
Su ZengInstitute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Jian-Qing GaoInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Wenhan BaoSchool of Life Sciences, Shandong University, Qingdao, 266237, China.
James BarnardDrug Product Development, Biological, Allergan, Irvine, California, 92612, USA.
Haibin WangZhejiang Hisun Bioray Biopharmaceutical Co., Ltd, Taizhou, Zhejiang, 318000, China.
Wei-Jie FangInstitute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. wjfang@zju.edu.cn.
Zhejiang University · CNZhejiang Hisun Pharmaceutical (China) · CNAcademy of Military Medical Sciences · CNAllergan (United States) · USShandong University · CN

Funding

Fundamental Research Funds for the Central Universities 2019XZZX003-18Ministry of Science and Technology of China 2018ZX09J18107-002National Natural Science Foundation of China 81741144
6 · The paper itself

Abstract

purposesThe main purposes of this article are to describe an unprecedented phenomenon in which significant amount of a shoulder peak impurity was observed during normal non-reducing capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) analysis of a recombinant fusion protein X, and to evaluate the root cause for this phenomenon.

methodsA series of experiments were conducted to study the nature of this degradation. Effects of iodoacetamide (IAM), heating temperature, duration, and SDS on the formation of this specific impurity were evaluated using a variety of characterization techniques.

resultsThe formation of the impurity as observed in CE-SDS was actually due to alkylation of lysine and serine residues with IAM, as confirmed by peptide mapping and LC-MS/MS, which increased the molecular weight and therefore decreased the electrophoretic mobility. The amount of impurity was also strongly dependent on sample preparation conditions including the presence or absence of SDS.

conclusionsOur study clearly suggested that even though IAM has been used extensively as an alkylation reagent in the traditional non-reducing CE-SDS analysis of monoclonal antibodies and other proteins, alkylation with IAM could potentially lead to additional impurity peak, and therefore complicating analysis. Therefore, before performing CE-SDS and other analyses, the effects of sample preparation procedures on analytical results must be evaluated. For protein X, IAM should be excluded for CE-SDS analysis.

Indexed as

Antibodies, MonoclonalChromatography, LiquidElectrophoresis, CapillaryElectrophoresis, Polyacrylamide GelRecombinant ProteinsSodium Dodecyl SulfateTandem Mass SpectrometryAntibodies, MonoclonalRecombinant ProteinsSodium Dodecyl SulfatealkylationCE-SDSimpurityLC-MSpeptide mappingsample preparation

Identifiers

PMID33098017
OpenAlexW3094386946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.